FDA Approved: VIBATIV — Supplemental Application (Cumberland Pharmaceuticals Inc.)

View source ↗

Summary

FDA approved a supplemental application for VIBATIV (telavancin hydrochloride) from Cumberland Pharmaceuticals, updating the labeling under the approved NDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Skin and Skin Structure Infections
• Hospital-acquired Pneumonia
• Ventilator-associated Pneumonia

Drugs mentioned

• Vibativ (telavancin)

Snippet

SUPPL AP for VIBATIV (TELAVANCIN HYDROCHLORIDE)